TONIX PHARMA LIMITED
21Patents
21Active
21Granted
48Portfolio score
Filing activity: May 5, 2008 → May 27, 2022 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10117936B2 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | Human Necessities | 21 | Active |
| US9474728B2 | Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine | Human Necessities | 15 | Active |
| US9636408B2 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | Human Necessities | 14 | Active |
| US9918948B2 | Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine | Human Necessities | 10 | Active |
| US10357465B2 | Eutectic formulations of cyclobenzaprine hydrochloride | Human Necessities | 9 | Active |
| US10322094B2 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | Human Necessities | 9 | Active |
| US9956188B2 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | Human Necessities | 6 | Active |
| US11026898B2 | Eutectic formulations of cyclobenzaprine hydrochloride | Human Necessities | 4 | Active |
| US10736859B2 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | Human Necessities | 4 | Active |
| US9314469B2 | Method for treating neurocognitive dysfunction | Human Necessities | 2 | Active |
| US10864175B2 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | Human Necessities | 2 | Active |
| US10722478B2 | Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine | Human Necessities | 2 | Active |
| US10864176B2 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | Human Necessities | 2 | Active |
| US11826321B2 | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions | Human Necessities | 1 | Active |
| US10449203B2 | Tianeptine oxalate salts and polymorphs | Human Necessities | 1 | Active |
| US11737991B2 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | Human Necessities | 1 | Active |
| US11839594B2 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | Human Necessities | 1 | Active |
| US12365879B2 | Synthetic chimeric poxviruses | Chemistry; Metallurgy | 0 | Active |
| US11998516B2 | Methods and compositions for treating depression using cyclobenzaprine | Human Necessities | 0 | Active |
| US12156897B2 | Magnesium-containing oxytocin formulations and methods of use | Human Necessities | 0 | Active |
| US10946027B2 | Tianeptine oxalate salts and polymorphs | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.